The specialized mesothelioma treatment and patient care available at Sidney Kimmel at Johns Hopkins makes it one of the best programs for mesothelioma patients on the East Coast.

Benefits of Sidney Kimmel

Founded in 1973, the Sidney Kimmel Cancer Center is a branch of the nationally recognized Johns Hopkins Hospital in Baltimore, Maryland. This cancer center is at the hub of some of the most promising treatments for mesothelioma patients in the country.

Why Sidney Kimmel?

  • Multidisciplinary Team

    Having a team of mesothelioma specialists from different disciplines is essential to getting the best treatment. From diagnosis to treatment, the team at Sidney Kimmel has experience treating mesothelioma at every step.

  • Clinical Trials

    Patients who are interested in clinical trials can turn to this cancer center for some of the latest trials in mesothelioma treatment. This cancer center has conducted research in immunotherapy, biomarkers for diagnosis and traditional treatment methods.

  • Patient Care

    This treatment center has a focus on patient and family care, as demonstrated by services such as their cancer counseling center and pain management programs. There is also housing available for families traveling from out of town to take advantage of their services.

Get Connected To Sidney Kimmel Cancer Center

Photograph of Sidney Kimmel Comprehensive Cancer Center
The Sidney Kimmel Cancer Center is one of the most reputable cancer centers in the nation. Their mesothelioma program has been essential to improving the lives of patients and the quality of treatment in mesothelioma care.

Why Choose Sidney Kimmel Cancer Center?
  • Improve survival rate with multimodal treatment
  • Expand your treatment options with access to clinical trials
  • Get treated by a team known for its patient-focused care




Mesothelioma Treatment at Sidney Kimmel

Recognizing that a proper diagnosis is essential to the best treatment possible, Sidney Kimmel has a second opinions program for patients with all types of lung malignancies, including mesothelioma. Second opinions can reveal new options in treatment for patients based on their stage or mesothelioma cell type.

The mesothelioma program at Sidney Kimmel features a full multidisciplinary treatment team. Having a multidisciplinary team is important to getting the best treatment available, especially since patients generally fare better when they are treated with several modes of therapy.

Sidney Kimmel has a full range of mesothelioma doctors specializing in radiation, oncology and surgery.

Meet the Specialists

Dr. Julie Brahmer is the medical oncologist of the mesothelioma program at the Sidney Kimmel Cancer Center. She is an experienced presenter who has shared her expertise about pain management and clinical trials for mesothelioma patients at various symposiums.

She is also the co-author of a study on the importance of mesothelioma patients managing fluid buildup in the lungs, a condition which can cause shortness of breath and difficulty breathing. Dr. Brahmer believes in the importance of addressing patient needs on an emotional, physical and spiritual level.

“Pain affects the mind, the body and the spirit and so it’s important for the medical team to assess the person with the pain, not just the pain itself.”
—Dr. Brahmer

Dr. Stephen Yang is the Chief of Thoracic Surgery at Sidney Kimmel. Mesothelioma patients who are candidates for surgery are treated by Dr. Yang. He treats his patients with a multimodal approach, combining surgery with treatments such as chemotherapy and radiation. He also studies mesothelioma at the molecular level, furthering the understanding of the behavior of the disease to develop more effective treatment methods.

Clinical Trials at Sidney Kimmel

The Sidney Kimmel Cancer Center has been involved in many clinical trials for mesothelioma. The cancer center has participated in clinical trials that have contributed to how mesothelioma is treated. Some trials that took place at Sidney Kimmel are:

  • Second-Line Therapy for Mesothelioma

    NGR-hTNF is a new second-line treatment with potential for preventing metastasis and tumor growth in mesothelioma patients. It is being tested on patients who have already had their first line of treatment with chemotherapy.

  • Attacking Mesothelioma Stem Cells

    Sidney Kimmel is participating in the Phase 2 study of defactinib, a drug that attacks mesothelioma stem cells and may prevent tumor recurrence, if the trial is successful.

  • Determining Genetic Risk

    With an eye on the future, Sidney Kimmel is contributing to research designed to assess if some patients are genetically predisposed to developing mesothelioma. This research could result in earlier diagnoses in the future.

Is Sidney Kimmel Right For You?

With an experienced mesothelioma program treating many patients every year, it’s no wonder patients seek out this cancer center. Mesothelioma patients often choose Sidney Kimmel for reasons including:

  • Home to top mesothelioma specialists
  • Wide variety of treatment options
  • Access to new clinical trials

If you think the Sidney Kimmel Comprehensive Cancer Center would fit your treatment needs, get in touch with their mesothelioma specialists today.